Literature DB >> 11114111

The measurement of prion protein in bovine brain tissue using differential extraction and DELFIA as a diagnostic test for BSE.

G Barnard1, B Helmick, S Madden, C Gilbourne, R Patel.   

Abstract

A simple diagnostic test for the detection of bovine spongiform encephalopathy (BSE), based on a commercially available time-resolved fluorescence immunoassay (DELFIA) for the measurement of the normal and disease-associated isoforms of prion protein (PrP), is described. The isoforms are sequentially extracted from homogenized bovine brain tissue using two concentrations of guanidine hydrochloride. This procedure initially extracts a soluble isoform and subsequently a less soluble disease-associated aggregated isoform. Following quantification of the two fractions, the percentage of the insoluble prion becomes a measurable parameter, independent of protein concentration, clearly identifying normal from infected animals displaying clinical signs of BSE. The mean percentages of insoluble PrP in brain tissue from 60 BSE-confirmed-positive cattle and 100 cattle that had never been exposed to the disease were 52.6% (SD = 22.8) and 3.9% (SD = 1.5), respectively. The assay is sensitive, with a detection limit of less than 50 pg PrP, and is robust and precise (CVs < 10%) over the appropriate working range. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114111     DOI: 10.1002/1522-7243(200011/12)15:6<357::AID-BIO621>3.0.CO;2-V

Source DB:  PubMed          Journal:  Luminescence        ISSN: 1522-7235            Impact factor:   2.464


  5 in total

1.  Comparison of dissociation-enhanced lanthanide fluorescent immunoassays to enzyme-linked immunosorbent assays for detection of staphylococcal enterotoxin B, Yersinia pestis-specific F1 antigen, and Venezuelan equine encephalitis virus.

Authors:  D R Smith; C A Rossi; T M Kijek; E A Henchal; G V Ludwig
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Chronic subclinical prion disease induced by low-dose inoculum.

Authors:  Alana M Thackray; Michael A Klein; Adriano Aguzzi; Raymond Bujdoso
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases.

Authors:  Reza Dabaghian; Inga Zerr; Uta Heinemann; Gianluigi Zanusso
Journal:  Prion       Date:  2008 Oct-Dec       Impact factor: 3.931

4.  Accumulation of prion protein in the brain that is not associated with transmissible disease.

Authors:  Pedro Piccardo; Jean C Manson; Declan King; Bernardino Ghetti; Rona M Barron
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

Review 5.  TSE diagnostics: recent advances in immunoassaying prions.

Authors:  Anja Lukan; Tanja Vranac; Vladka Curin Šerbec
Journal:  Clin Dev Immunol       Date:  2013-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.